Authors are invited to submit abstracts for the upcoming 23^rd International Myeloma Society Annual Meeting, held September 23-26, 2026 in Glasgow, Scotland.

During the prestigious IMS Annual Meeting, myeloma experts from around the world gather to discuss basic, preclinical, and clinical aspects of multiple myeloma. Abstracts presenting new research or expanding existing studies are encouraged. Be sure to complete all steps and to finalize the abstract submission. Only finalized submissions will be evaluated. Note that you will receive an email stating your submission is complete. If you did not receive this email, please verify that it is complete and not saved as a draft.

All abstracts will be blinded and peer reviewed. Authors will be notified in early July 2026 if their abstract has been accepted. Presenting authors must register for the Annual Meeting.

Abstract submissions are also invited for the 10th Nursing and Allied Health Symposium. Select the “Nursing and Allied Health” track when submitting.

Oral Abstract – Limited number selected for oral presentation.

Poster Abstract – Physical posters presented during dedicated sessions.

Nursing and Allied Health – Submit for the 10th Nursing and Allied Health Symposium.

Include name, email address, and institutional affiliation for all co-authors (maximum of 25). Identify one presenting author per abstract.

An automatic email will be sent to all authors to verify their information. Authors submitting multiple abstracts should plan for alternate presenters.

Responsibility of Abstract Submitters

• Commitment to present if accepted
• Encore abstracts permitted; new data encouraged
• Consent required for use of recognizable images
• Compliance with IRB or equivalent research standards

Responsibility of Abstract Presenters

• Present the abstract if accepted
• Disclose financial and non-financial relationships
• Review presentation guidelines and RSVP acceptance
• Register for the IMS Annual Meeting

Young Investigator Award

Through the IMS Young Investigator Awards, the International Myeloma Society provides travel grants to young myeloma researchers to assist with expenses relating to their participation at the International Myeloma Society Annual Meeting. 

Eligible applicants must be:

• Age 35 years or younger
• Registered at the IMS Annual Meeting
• Have an abstract selected for oral or poster presentation at the International Myeloma Society Annual Meeting
• The awardee must be the primary author on the submitted abstract

To be considered, please select Yes to the Young Investigator Award question during the abstract submission process online. More details on the Young Investigator Award are available here.

Nursing and Allied Health Symposium Abstract Award

All abstracts submitted for the Nursing and Allied Health Symposium will be eligible to be considered for the Nursing and Allied Health Symposium Abstract Award. No additional information is required for consideration.

Eligibility:

• The awardee must be the primary author on the submitted abstract
• Must be registered for the Nursing and Allied Health Symposium or full IMS Annual Meeting